2014 has been a blockbuster year for mergers and acquisitions so far. February alone saw global M&A deals worth $251 billion - the most since 2012, according to Standard Life Investment.
Among the biggest names in the news, Bayer said it will acquire the consumer care business of U.S.-based Merck for $14.2 billion in cash and General Electric offered $12.5 billion for the energy arm of French industrial engineering firm Alstom.
Read MoreM&A fever – the coming epidemic
Out of these three deals, which represents the best value for shareholders?